Angio Suites Market Report 2024

This Angio Suites market report covers industry characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The angio suites market size has grown strongly in recent years. It will grow from $1.66 billion in 2023 to $1.78 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%. The growth during the historic period can be attributed to the increasing incidence of cardiovascular diseases, the expansion of outpatient surgical procedures, higher healthcare expenditure, improved patient outcomes, and a shift towards minimally invasive procedures.

The angio suites market size is expected to see strong growth in the next few years. It will grow to $2.36 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The growth during the forecast period can be attributed to the increasing elderly population, the expansion of outpatient and ambulatory surgeries, a rising prevalence of chronic diseases, a greater emphasis on early diagnosis, and heightened health awareness. Key trends expected in this period include technological advancements, a focus on minimally invasive procedures, integration with electronic health records, the development of advanced imaging systems, and the use of robotic-assisted technologies.

The increasing prevalence of cardiovascular disease is projected to drive the growth of the angio suites market in the future. Cardiovascular disease encompasses a variety of conditions affecting the heart and blood vessels, such as coronary artery disease, heart attacks, strokes, and hypertension. Contributing factors like sedentary lifestyles, poor diet, and high obesity rates exacerbate cardiovascular issues. Angio suites offer advanced imaging and interventional capabilities that enable precise diagnosis and treatment of complex cardiovascular conditions through real-time visualization and minimally invasive techniques. For example, in January 2024, the American Heart Association reported that deaths from cardiovascular diseases reached 931,578, an increase of fewer than 3,000 from 928,741 in 2023. Additionally, the age-adjusted death rate from cardiovascular diseases rose to 233.3 per 100,000, reflecting a 4% increase from the previous year's rate of 224.4 per 100,000. Thus, the rise in cardiovascular diseases is expected to boost the angio suites market.

Leading companies in the angio suites market are incorporating advanced imaging technologies, such as biplane angiography systems, to enhance diagnostic precision, increase procedural efficiency, and offer comprehensive visualization for complex vascular interventions. The biplane angiography system is a sophisticated imaging technology that captures two perpendicular X-ray images of the vascular system simultaneously, providing detailed, real-time views to aid in complex interventional procedures and improve diagnostic accuracy. For example, in June 2022, Siemens Healthineers, a Germany-based provider of medical technology specializing in imaging, diagnostics, and advanced therapies, introduced the ARTIS icono. This biplane angiography system is designed for comprehensive diagnostic imaging and interventional treatments, supporting procedures such as neuro-angiography, general and cardiac angiography, and interventional radiology, and accommodating both obese and pediatric patients. It combines X-ray, image fusion, and navigation technologies, making it suitable for image-guided surgeries in the operating room.

In April 2021, Siemens Healthineers, a Germany-based medical technology firm, acquired Varian Medical Systems, Inc. for an undisclosed sum. This acquisition is intended to strengthen Siemens Healthineers' position in the healthcare sector. With the addition of Varian, Siemens Healthineers now holds the most comprehensive portfolio in the MedTech industry, presenting significant opportunities for value creation. Varian Medical Systems Inc., a US-based company, specializes in developing interventional angiography systems.

Major companies operating in the angio suites market are Medtronic Plc, FUJIFILM Holdings Corporation, Siemens Healthineers, Koninklijke Philips N.V., GE Healthcare, Boston Scientific Corporation, B. Braun Melsungen AG, Hologic Inc., Mindray Medical International Limited, Agfa-Gevaert Group, Shimadzu Corporation, Canon Medical Systems Inc., Cook Medical LLC, Carl Zeiss AG, Elekta AB (publ), Planmeca Oy, Carestream Health Inc., Guerbet Group, 3D Systems Inc., Ziehm Imaging GmbH, Surgical Science Sweden AB, IMRIS Inc., Allengers Medical Systems Limited, Lam Vascular and Associates Inc., NeuroLogica Corporation.

North America was the largest region in the angio suites market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angio suites market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the angio suites market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

An angio suite is a specialized facility within a hospital or clinic designed for performing minimally invasive, image-guided procedures, particularly those involving the vascular system (blood vessels). The term "angio" refers to blood vessels, while "suite" denotes the equipped room or area where these procedures are conducted. The primary goal of an angio suite is to offer a controlled environment for interventional radiology procedures.

Angio suites are typically categorized into single-plane and bi-plane types. Single-plane angio suites are equipped with imaging systems that capture images from a single angle, making them suitable for straightforward procedures and diagnostics. The technology in these suites includes X-ray angiography, computed tomography (CT) angiography, magnetic resonance angiography (MRA), and other imaging modalities. Applications of angio suites encompass cardiac angiography, neurology angiography, oncology angiography, peripheral vascular angiography, and more. These suites are utilized by hospitals, ambulatory surgical centers, diagnostic imaging centers, and other healthcare facilities.

The angio suites market research report is one of a series of new reports that provides angio suites market statistics, including angio suites industry global market size, regional shares, competitors with an angio suites market share, detailed angio suites market segments, market trends and opportunities, and any further data you may need to thrive in the angio suites industry. This angio suites market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The angio suites market consists of revenues earned by entities by providing services such as installation, maintenance, and servicing of angiography equipment, as well as the training and support provided to healthcare professionals using these system. The market value includes the value of related goods sold by the service provider or included within the service offering. The angio suites market also includes sales of sales of angiography systems, 3D imaging systems, image fusion systems, and radiation protection equipment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.